CRAIG A TOOMAN Insider Trading $ENZN ENZON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CRAIG A TOOMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CRAIG A TOOMAN. CRAIG A TOOMAN is Exec VP Finance, CFO in ENZON PHARMACEUTICALS, INC. ($ENZN) and Exec. VP Finance, CFO in ENZON PHARMACEUTICALS, INC. ($ENZN).
CRAIG A TOOMAN in ENZON PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CRAIG A TOOMAN: Exec. VP Finance, CFO, Exec VP Finance, CFO
Holdings: 128,096 shares
Current Value: $44,834
Latest Transaction: Feb 26 2010
$ENZN Market Capitalization: $15.28M
$ENZN Previous Close: $0.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CRAIG A TOOMAN in ENZON PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Option Exercise | M | 6.97 | 50,000 | 348,500 | 0 | |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Option Exercise | M | 5.73 | 50,000 | 286,500 | 0 | |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Option Exercise | M | 6.95 | 50,000 | 347,500 | 0 | |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Sell | S | 9.27 | 150,000 | 1,390,635 | 128,096 | 278.1 K to 128.1 K (-53.94 %) |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Buy | M | 6.97 | 50,000 | 348,500 | 278,096 | 228.1 K to 278.1 K (+21.92 %) |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Buy | M | 5.73 | 50,000 | 286,500 | 228,096 | 178.1 K to 228.1 K (+28.07 %) |
| Feb 26 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. VP Finance, C ... | Buy | M | 6.95 | 50,000 | 347,500 | 178,096 | 128.1 K to 178.1 K (+39.03 %) |
| Jan 06 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Payment of Exercise | F | 10.77 | 4,157 | 44,771 | 123,610 | 127.8 K to 123.6 K (-3.25 %) |
| Jan 06 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | J | 0.00 | 10,000 | 0 | 127,767 | 117.8 K to 127.8 K (+8.49 %) |
Page: 1